Benign_and_malignant_tumors_in_patients_with_acromegaly._Growth_hormone_and_its_principal_mediator_insulinlike_growth_factor_I_are_known_promoters_of_normal_growth._To_determine_whether_excessive_secretion_of_growth_hormone_is_associated_with_an_increased_occurrence_of_benign_and_of_malignant_tumors,_we_studied_records_of_87_patients_with_acromegaly_seen_in_the_Lahey_Clinic_Medical_Center_(Burlington,_Mass)_from_1957_to_1988_and_compared_the_rate_of_tumor_occurrence_with_a_control_group_of_patients_with_pituitary_tumors_(198)_and_with_findings_from_a_cancer_registry._Patients_with_acromegaly_had_a_2.45-fold_increased_rate_of_malignant_tumors_(95%_confidence_interval,_0.98_to_5.04)_compared_with_findings_from_the_tumor_registry._Female_patients_had_a_higher_rate_than_male_patients._The_rate_of_carcinoma_of_the_thyroid_was_excessive_and_previously_underscribed,_but_the_rate_of_carcinoma_of_the_colon_was_not_increased_as_reported_by_others._Among_benign_lesions,_goiters,_predominantly_nodular,_were_seen_in_25%_of_patients_in_addition_to_a_large_number_of_mesenchymal_lesions.